Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

The Pharmaceutical Journal

Editorial

View of the Houses of Parliament, Westminster, London

Access to Medical Treatments (Innovation) Bill will not serve healthcare professionalsSubscription

A bill claiming to help medical practitioners access innovative treatments has healthcare professions scratching their heads — because it wasn’t needed in the first place.

Close up of meningococcal septicaemia rash

Meningitis B vaccine: basing decisions on evidence not emotionsSubscription

Public opinion should be listened to when it comes to healthcare policies, but must not influence methodological, evidence-based decision making.

Comment

Pharmacy store sign offering NHS community services

Government cuts to community pharmacy: the perspective of grassroots pharmacistsSubscription

By

How should pharmacy respond to major funding cuts for community pharmacy? Community pharmacists and pharmacy owners give their views.

Retro illustration of a megaphone representing communication

Government cuts to community pharmacy: the perspective of leaders

By

How should pharmacy respond to major funding cuts for community pharmacy? Leaders from pharmacy organisations and primary care share their views.

Collage of faces of over 100 men and very few women representing sex bias in drug research

Sex bias in drug research: a call for changeSubscription

By

Because medical and drug research is conducted mainly on men, there can be dangerous consequences for women who receive the same treatment.

Q&A

Heidi Alexander, pictured, MP for Lewisham East and was appointed Shadow Secretary of State for Health, explains why she wants to start a major public debate about how best to fund a health and care service for the 21st century

Q&A: Heidi Alexander — how do you solve a problem like a financially crippled NHS?Subscription

By

Heidi Alexander discusses her concerns about the UK government’s current health plans and explains why she wants to start a public debate about how to fund a health and care service for the 21st century.

Learning article

Two healthcare professionals discuss a subject matter in a hospital

How to make an oral case presentation to healthcare colleaguesSubscription

By ,

The content and delivery of a patient case for education and evidence-based care discussions in clinical practice.

Pharmacists talking in a dispensary

How to give and receive constructive feedbackSubscription

By , , , ,

The importance of feedback and how to deliver it in a clinical environment.

Careers

Stewart Adams, pictured, discoverer of ibuprofen, talks about why he researched the drug and how he tested it on himself

The man who discovered ibuprofenSubscription

By

Ibuprofen is one of the world’s best selling anti-inflammatory painkillers. Its pioneer, Stewart Adams, now 92 years old, tells Julia Robinson about how and why his discovery came to fruition.

News

Osteoarthritis is leading cause of pain in older patients

Paracetamol ineffective in treating osteoarthritis, meta-analysis findsSubscription

Paracetamol is not clinically effective for alleviating pain and improving physical function in patients with osteoarthritis, the largest analysis of randomised trials of analgesics for osteoarthritis published to date has found. 

George Osborne outside Downing Street before the 16 March 2016 budget

Sugar tax to be imposed on companies that produce soft drinks from 2018Subscription

A levy on soft drinks companies marketing products with added sugar will be come into effect from April 2018, UK chancellor George Osborne announced in the budget on 16 March 2016

The Pharmaceutical Journal

March 2016, Vol 295, No 7887

Cover Story:

Following intriguing genetic discoveries in people with extreme sensitivity to pain, as well as some families who feel no pain at all, researchers and drug companies are optimistic that blocking a sodium channel called Nav1.7 may lead to a new generation of more sophisticated painkillers. Meanwhile, however, there is still debate about the underlying mechanism of Nav1.7 in pain.

Read more…

The Pharmaceutical Journal

View previous issue

Notice-board

For latest notifications, opportunities and product updates, visit the notice-board page here.

Announcements

For official announcements from The Royal Pharmaceutical society please visit the announcements page here.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.